Non-covalent formulation of active principles with dendrimers: current state-of-the-art and prospects for further development
dc.contributor.author | Elkin, Igor | |
dc.contributor.author | Banquy, Xavier | |
dc.contributor.author | Barrett, Christopher J. | |
dc.contributor.author | Hildgen, Patrice | |
dc.date.accessioned | 2018-04-25T18:18:11Z | |
dc.date.available | MONTHS_WITHHELD:12 | fr |
dc.date.available | 2018-04-25T18:18:11Z | |
dc.date.issued | 2017-09-06 | |
dc.identifier.uri | http://hdl.handle.net/1866/19944 | |
dc.publisher | Elsevier | fr |
dc.subject | Dendrimer | fr |
dc.subject | Active principle | fr |
dc.subject | Non-covalent dendrimer-drug-association | fr |
dc.subject | Drug-formulation | fr |
dc.subject | Physico-chemical mechanisms | fr |
dc.subject | Bio-distribution | fr |
dc.subject | Biosafety | fr |
dc.title | Non-covalent formulation of active principles with dendrimers: current state-of-the-art and prospects for further development | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de pharmacie | fr |
UdeM.statut | Professeur(e) / Professor | fr |
dc.identifier.doi | 10.1016/j.jconrel.2017.09.002 | |
dcterms.abstract | During the last three decades, dendrimers, nano-sized highly-branched fractal-like symmetrical macromolecules, have been intensively studied as promising candidates for application as drug-delivery carriers. Among other important characteristics arising from their unique and highly-controlled architecture, size and surface properties, the possibility of hosting guest molecules in internal voids represents a key advantage underlying the potential of dendrimers as non-covalent drug-encapsulating agents. The impressive amount of accumulating experimental results to date allows researchers to identify the most important and promising theoretical and practical aspects of the use of dendrimers for this purpose. This review covers the main factors, phenomena, and mechanisms involved in this drug-vectorization approach, including mechanisms of non-covalent dendrimer-drug association, dendrimer-dendrimer interactions, as well as biological properties relevant to the host dendrimers. A discussion is then provided to illustrate some successful existing formulation strategies as well as to propose some new possible ones to optimize further development of the field. | fr |
dcterms.isPartOf | urn:ISSN:0168-3659 | |
dcterms.isPartOf | urn:ISSN:1873-4995 | |
dcterms.language | eng | fr |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | fr |
oaire.citationTitle | Journal of controlled release | |
oaire.citationVolume | 264 | |
oaire.citationStartPage | 288 | |
oaire.citationEndPage | 305 |
Fichier·s constituant ce document
Ce document figure dans la ou les collections suivantes
Ce document diffusé sur Papyrus est la propriété exclusive des titulaires des droits d'auteur et est protégé par la Loi sur le droit d'auteur (L.R.C. (1985), ch. C-42). Il peut être utilisé dans le cadre d'une utilisation équitable et non commerciale, à des fins d'étude privée ou de recherche, de critique ou de compte-rendu comme le prévoit la Loi. Pour toute autre utilisation, une autorisation écrite des titulaires des droits d'auteur sera nécessaire.